Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide (Q56483757)

0 references

Samantha Mayer

0 references

Jürgen Michaelis

0 references

Alan R. Hipkiss

0 references

Renate Müller

0 references

Arne Neumann

0 references

Reinhard Schinzel

0 references

Anne M. Cunningham

BBA: Molecular Basis of Disease

0 references

publication date

February 1997

0 references

published in

0 references

volume

1360

0 references

issue

0 references

page(s)

17-29

0 references

cites work

Biochemistry of Alzheimer's disease amyloid plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Cellular and molecular biology of Alzheimer's disease and animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

New Alzheimer's therapy suggested

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Protein fructosylation: fructose and the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Carnosine protects proteins against in vitro glycation and cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Neuritic plaque amyloid in Alzheimer's disease is highly racemized

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Non‐enzymatic glycosylation of the dipeptide l‐carnosine, a potential anti‐protein‐cross‐linking agent

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Natural histidine-containing dipeptide carnosine as a potent hydrophilic antioxidant with membrane stabilizing function. A biomedical aspect

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

The significance of the Maillard reaction in human physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Age as risk factor for sporadic dementia of the Alzheimer type?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Retardation of the senescence of cultured human diploid fibroblasts by carnosine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Alzheimer's disease. A glycation connection.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Nonenzymatic glycation interferes with protein concentration determinations

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Serum advanced glycosylation end products: a new class of uremic toxins?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Blood-brain glucose transfer: repression in chronic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Pathways of Formation of Glycoxidation Products during Glycation of Collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2896%2900062-2

7 January 2021